期刊文献+

慢性阻塞性肺病急性加重期患者血浆D-二聚体的临床意义和CRP的相关性 被引量:2

Chronic Obstructive Pulmonary Disease Acute Exacerbation Patients with Clinical Significance of Plasma D-dimer and CRP Correlation
下载PDF
导出
摘要 目的探讨慢性阻塞性肺病急性加重期(AECOPD)患者D-二聚体的变化及其与CRP的相关性。方法选择慢性阻塞性肺病急性期患者38例及其经治疗稳定期患者31例和正常对照组患者,测定血浆D-二聚体及CRP含量,研究其变化,并对CRP与血浆D-二聚体水平的相关性进行分析。结果 AECOPD患者治疗前血浆D-二聚体、CRP水平明显高于COPD稳定期及正常对照组,COPD稳定期血浆D-二聚体、CRP水平高于正常对照组,患者的CRP与血浆D-二聚体呈正相关的关系。结论血浆中的D-二聚体可作为反映AECOPD患者病情的理想指标,对治疗效果的判断有重要的价值。 Objective To investigate the acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in patients with D-dimer changes and its correlation with CRP. Methods Choose 38 patients with acute phase of chronic obstructive pulmonary disease and the treatment of patients with 31 patients with stability and normal control group, plasma D-dimer and CRP levels to study its changes, and plasma D-dimer levels of CRP and the correlation analysis. Results AECOPD patients plasma D-dimer and CRP levels before treatment was significantly higher stability and normal control group, COPD stabilization of plasma D-dimer, CRP levels higher than the normal control group, patients with CRP was positively correlated with plasma D-dimer. Conclusion Plasma D-dimer can be used as an ideal index to reflect the AECOPD of the patient's condition, have important value to judge the curative effect.
出处 《中国医药指南》 2014年第14期23-24,共2页 Guide of China Medicine
关键词 慢性阻塞性肺病 D-二聚体 CRP Chronic obstructive pulmonary disease D-dimer CRP
  • 相关文献

参考文献4

二级参考文献17

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3041
  • 3Fine MJ, Auble TE, Yearly DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med, 1997,336 : 243 -250.
  • 4Lim WS, van der Earden MM, laing R, et al. Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study. Thorax,2003,58:377-382.
  • 5Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med,2008,121:219-225.
  • 6Menendez R, Cavalcanti M, Reyes, et al. Markers of treatment failure in hospitalized eommtmity acquired pneumonia. Thorax,2008,63:447-452.
  • 7Bircan A, Kaya O, Gokirmak M, et al. C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia. Tuberk Toraks,2006,54 : 22-29.
  • 8Kim GY, Park SY, Yoon HY, et al. Investigation of hemostatic changes in patients with sepsis. Korean J Lab Med,2007,27:157-161.
  • 9Guneysel O, Pirmit S, Karakurt S. Plasma d-dimer levels increase with the severity of community acquired pneumonia. Tuberkuloz ve Toraks Dergisi, 2004,52 : 341-347.
  • 10Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma d-Dimer levels correlate with outcomes in patients with community acquired pneumonia. Chest,2004,126 : 1087-1092.

共引文献8239

同被引文献19

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部